FdaApplication
NDA 019297
Identifiers
- fda_app_no: NDA019297
Properties
| Property | Value |
|---|---|
| applicant_name | EMD SERONO INC |
| application_type | NDA |
| approval_date | 1987-12-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NOVANTRONE | MITOXANTRONE HYDROCHLORIDE | EQ 20MG BASE/10ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| NOVANTRONE | MITOXANTRONE HYDROCHLORIDE | EQ 30MG BASE/15ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| NOVANTRONE | MITOXANTRONE HYDROCHLORIDE | EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
3 products